FDA approves new oral treatment for multiple sclerosis - FDA Press Releases

FDA approves Mayzent (cladribine), a new oral drug to treat multiple sclerosis

from Food and Drug Administration--Press Releases https://ift.tt/2FFr2re
via IFTTT